These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38688468)

  • 1. Effect of hormone therapy on blood pressure and hypertension in postmenopausal women: a systematic review and meta-analysis.
    Ferreira Campos L; de Andrade Costa G; Domingues Feitosa M; Ferreira Félix I; Gabrielli L; C Almeida MDC; Ml Aquino E; Aras Júnior R
    Menopause; 2024 Jun; 31(6):556-562. PubMed ID: 38688468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and benefit considerations for menopausal hormone therapy.
    Pickar JH; Archer DF; Kagan R; Pinkerton JV; Taylor HS
    Expert Opin Drug Saf; 2017 Aug; 16(8):941-954. PubMed ID: 28664754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hormone therapy and incident gout: population-based case-control study.
    Bruderer SG; Bodmer M; Jick SS; Meier CR
    Menopause; 2015 Dec; 22(12):1335-42. PubMed ID: 25968834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials.
    Jiang X; Aragaki AK; Nudy M; Manson JE; Shadyab AH; Wild RA; Valdiviezo C; Gass M; Martin LW; Pan K; Stefanick ML; Robbins JA; Schnatz PF
    Menopause; 2023 Jan; 30(1):28-36. PubMed ID: 36256926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women.
    Velthuis-Te Wierik EJ; Hendricks PT; Martinez C
    Menopause; 2007; 14(3 Pt 1):518-27. PubMed ID: 17224856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different menopausal hormone regimens and risk of breast cancer.
    Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
    Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
    Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
    Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?
    Falk RT; Manson JE; Barnabei VM; Anderson GL; Brinton LA; Rohan TE; Cauley JA; Chen C; Coburn SB; Pfeiffer RM; Reding KW; Sarto GE; Wentzensen N; Chlebowski RT; Xu X; Trabert B
    Int J Cancer; 2019 Feb; 144(4):730-740. PubMed ID: 30183089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose hormone therapy in postmenopausal women in China.
    Zang H; Shi H; Speroff L
    Climacteric; 2010 Dec; 13(6):544-52. PubMed ID: 19938946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
    Roach RE; Lijfering WM; Helmerhorst FM; Cannegieter SC; Rosendaal FR; van Hylckama Vlieg A
    J Thromb Haemost; 2013 Jan; 11(1):124-31. PubMed ID: 23136837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hormone therapy on the ocular surface and intraocular pressure for postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Hao Y; Xiaodan J; Jiarui Y; Xuemin L
    Menopause; 2020 Aug; 27(8):929-940. PubMed ID: 32520901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.